$VERX

Vertex stock tumbles on cloud growth miss, price target cuts

Vertex Inc. (NASDAQ:VERX) shares dropped 13.2% after its Q2 results missed cloud growth expectations and analysts cut price targets. DA Davidson lowered its target to $12 from $15, citing slower cloud conversions and reduced FY26 cloud growth guidance to 18% from 25%. Other analysts also adjusted targets following guidance and deal-cycle comments.

Original reporting
Published Aug 4, 2026, 3:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 3:40 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$VERX
Bearish
medium confidence
Mentioned
$VERX
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$VERXBearishMed
01

Why it matters

The immediate trading driver is the combination of a cloud growth miss, a guidance cut, and multiple analyst price-target reductions, which can drive further estimate revisions and risk-off positioning.

02

Market read

Traders can use the guidance cut (FY26 cloud growth to 18% from 25%) and the analyst target changes to reassess near-term expectations and downside risk for VERX.

03

What to watch

The article mentions elongated deal cycles and uneven migration trends, so the selloff may over-discount timing effects rather than long-term demand; also, the executive appointments could support execution focus, though no direct performance link is provided.

Relevance 7/10Novelty 5/10Timing: Tuesday after-hours/next-session positioning following the 2Q cloud-growth miss and guidance cut.

Background

The piece frames Vertex’s 2Q26 results as slightly above consensus but with a specific shortfall in cloud conversions, leading to a FY26 cloud growth guidance reduction.

Company-level read

Ticker impact

$VERXBearishMedium confidence
Context

Vertex shares fell 13.2% after 2Q results, with analysts cutting price targets on missed cloud growth and reduced FY26 cloud guidance.

Expected impact

Bearish bias for the next several sessions as revisions to cloud-conversion expectations and FY26 growth guidance filter through.

Evidence & confidence

The article cites slower cloud conversions, a guidance cut from 25% to 18%, and multiple analyst price-target reductions, which typically reinforce downside risk to estimates and valuation.

Market effects

Signals caution for enterprise cloud migration and IT spend conversion rates, which can pressure other cloud-adjacent software/services names via read-across.

Limited direct regional spillover; impact is primarily company-specific within US software/IT services sentiment.

Moderate, as cloud migration deal cycles and conversion dynamics are global themes but the article is focused on Vertex.

Counterpoint

Despite the cloud-growth miss, analysts still point to potential re-acceleration catalysts in 4Q (e-invoicing ramp) and early-stage AI revenue, which could stabilize expectations if execution improves.

Key entities

  • Vertex Inc.

    Subject of the article; shares fell 13.2% after missing cloud growth expectations and cutting FY26 cloud growth guidance.

  • Lucky Schreiner

    DA Davidson analyst who cut the price target to $12 from $15 and cited slower cloud conversions.

  • Daniel Jester

    BMO Capital analyst who raised the price target to $15 from $14, maintaining Market Perform.

  • Brett Huff

    Stephens analyst who lowered the price target to $18 from $20 while keeping Overweight.

  • Rob Oliver

    Baird analyst who cut the price target to $17 from $19 while keeping Outperform.

Related articles

$VERXMedAI 8/10

Vertex Q2 Earnings Call Highlights

Vertex (NASDAQ:VERX) said slower cloud conversion is a timing issue, with customers using mixed cloud and on-prem deployments. Management highlighted strong e-invoicing momentum ahead of France and Germany mandates, expecting e-invoicing to affect ARR in Q3 and more in Q4. Q3 guidance: revenue $208M-$211M, adj. EBITDA $55M-$57M; full-year revenue $825M-$830M and adj. EBITDA $206M-$210M.

$VERXMedAI 8/10

Why is Vertex stock sliding today?

Vertex Pharmaceuticals shares fell 12.8% after its post-close Q2 2026 results. The company reported EPS of $0.20 vs $0.19 consensus and revenue of $203.97M vs $202.29M forecast, but Q3 2026 revenue guidance of $208M-$211M (midpoint below ~$211.69M consensus) and free cash flow of $2.7M disappointed. Morgan Stanley downgraded to Equal Weight and cut its price target to $15 from $19.

$VERXMedAI 8/10

Vertex Announces Second Quarter 2026 Financial Results

Vertex, Inc. (NASDAQ: VERX) reported Q2 2026 results for the quarter ended June 30, 2026. Total revenue rose 10.5% to $204.0 million, with software subscription revenue up 10.7% to $174.8 million and cloud revenue up 17.9% to $101.7 million. Adjusted EBITDA increased to $51.0 million. Outlook: Q3 revenue $208.0-$211.0 million and adjusted EBITDA $55.0-$57.0 million; FY 2026 revenue $825.0-$830.0 million and adjusted EBITDA $206.0-$210.0 million.

$VERXHigh

Vertex, Inc. (VERX): Results of Operations and Financial Condition

Vertex, Inc. (VERX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 verx-20260803xex99d1.htm EX-99.1 ​ Exhibit 99.1 Vertex Announces Second Quarter 2026 Financial Results KING OF PRUSSIA, PA – August 3, 2026: Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), the Decision-to-Defense™ global indirect tax and compliance company, tod